A systematic analysis of human clinical trials reveals that pyrroloquinoline quinone (PQQ), a naturally occurring micronutrient, produces measurable improvements across three critical health markers at remarkably modest daily doses. The compound, found in fermented foods and kiwi fruit, demonstrated consistent benefits when taken at 5–20 mg daily—substantially lower than typical pharmaceutical doses.
Researchers documented dose-specific effects: anti-inflammatory benefits at 5–10 mg daily, enhanced mitochondrial energy production at approximately 20 mg daily, and improved memory and cognitive performance at 10–20 mg daily. These findings suggest PQQ may support cellular aging and metabolic health through multiple biological pathways. The evidence base, drawn from multiple human trials, positions PQQ as a practical nutritional intervention worthy of further investigation in aging populations and metabolic disorders.
Read the full article on GMJ Newsroom.
Was this article helpful?
